Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LHFPL tetraspan subfamily member 5 protein (LHFPL5) is a four-transmembrane domain protein in the tetraspan superfamily, acting as an auxiliary subunit of the mechanotransducer (MET) cation channel complex at the tips of stereocilia in cochlear hair cells[10][2][3]. It is essential for sensory transduction in the auditory system by facilitating the functional assembly and trafficking of the MET channel complex, coupling PCDH15 to the transduction channel, and ensuring the correct morphogenesis of hair bundles. Pathogenic mutations in LHFPL5 result in autosomal recessive nonsyndromic sensorineural hearing loss (DFNB67) in humans and corresponding deafness and vestibular phenotypes in animal models[1][2][3][7][11][10]. No approved drugs target LHFPL5, and it is not currently considered a direct therapeutic target for pharmacological intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LHFPL tetraspan subfamily member 5 protein (LHFPL5).